Two early studies, analyzing apparently largely overlapping cohorts of 111 [89] or 96 [90] DLBCL cases, identified REL copy number amplifications of four or more copies in 23% of the patients. This evidence concerns the gene REL and diffuse large B-cell lymphoma.